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The authors would like to publish an erratum to correct the mistakes in Fig. 4 legend and in the text under the heading "Study Assessments and Endpoints" in the published article. The correct texts are given below.Under the Fig. 4 legend the text currently reads: "a Partial clearance defined as ≤75% reduction in the number of clinically visible AK lesions. 5-FU/SA 5-fluorouracil 0.5%/salicylic acid 10%, AK actinic keratosis".The figure "≤75%" should be "≥75%".The first paragraph of "Study Assessments and Endpoints" has repeated text. The text "and proportional change from baseline in the total number of lesions at each treatment visit and 8 weeks after the end of treatment." should be removed.

The online version of the original article can be found under doi:10.1007/s13555-016-0161-2.
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